OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
Kamonpan Sanachai, Tuanjai Somboon, Patcharin Wilasluck, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269563-e0269563
Open Access | Times Cited: 14

Showing 14 citing articles:

Design, Synthesis, and Antiviral Activity of Fragmented-Lapatinib Aminoquinazoline Analogs towards SARS-CoV-2 Inhibition
Ayomide Olamide Adediji, Akeanan Sroithongmoon, Aphinya Suroengrit, et al.
European Journal of Medicinal Chemistry (2025), pp. 117303-117303
Closed Access

Molecular Mechanisms Underlying the Decolorization of Indigo Carmine and Coomassie Blue R-250 by Streptomyces salinarius CS29 Laccase
Kamonpan Sanachai, Bodee Nutho, Rakrudee Sarnthima, et al.
Biocatalysis and Agricultural Biotechnology (2025), pp. 103513-103513
Closed Access

A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice
Suchada Kaewin, Wanangkan Poolsri, Gül Gizem Korkut, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115158-115158
Open Access | Times Cited: 5

Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CLpro through Structure-Based Virtual Screening and Experimental Approaches
Piyatida Pojtanadithee, Kowit Hengphasatporn, Aphinya Suroengrit, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5244-5258
Closed Access | Times Cited: 5

PACT inhibits the replication of SARS‐CoV‐2 through the blockage of GSK‐3β‐N‐nsp3 cascade
Yingying Lin, Roubin Yao, Jiaxin Zhuang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 4

N-Containing α-Mangostin Analogs via Smiles Rearrangement as the Promising Cytotoxic, Antitrypanosomal, and SARS-CoV-2 Main Protease Inhibitory Agents
Nan Yadanar Lin Pyae, Arnatchai Maiuthed, Wongsakorn Phongsopitanun, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 3

Molecular Docking and Dynamics Identify Potential Drugs to be Repurposed as SARS-CoV-2 Inhibitors
Mohammed Muzaffar-Ur-Rehman, Chougule Kishore Suryakant, Ala Chandu, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 137-159
Open Access | Times Cited: 3

A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
Pitchayathida Mee-udorn, Kochakorn Phiwkaow, Ruchanok Tinikul, et al.
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35580-35591
Open Access | Times Cited: 2

Page 1

Scroll to top